Study finds US drug approvals 2010–2019 align with US, but not global, burden of disease
Drug approvals in the United States between 2010–2019 were aligned with the US, but not global, burden of disease and the increasing number of expedited drug approvals could make the gap worse according to a study in the ...
Mar 12, 2024
0
0